We are live on
!
Find out more
Agios Pharmaceuticals
AGIO
AGIO
232 hedge funds and large institutions have $2.12B invested in Agios Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 81 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
620% more call options, than puts
Call options by funds: $127M | Put options by funds: $17.6M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
27% more capital invested
Capital invested by funds: $1.67B → $2.12B (+$452M)
2.54% more ownership
Funds ownership: 105.05% → 107.59% (+2.5%)
1% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 81
0% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 36
2% less funds holding
Funds holding: 237 → 232 (-5)
Holders
232
Holders Change
-5
Holders Change %
-2.11%
% of All Funds
2.86%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.06%
New
36
Increased
82
Reduced
81
Closed
36
Calls
$127M
Puts
$17.6M
Net Calls
+$109M
Net Calls Change
+$22M
Top Buyers
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$71.8M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$42.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$23.9M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$14.9M |
| 5 |
BlackRock
New York
|
+$14.7M |
Top Sellers
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$32.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20.7M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$18.6M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$17.5M |
| 5 |
Jane Street
New York
|
-$12.4M |
